 |
|
Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer Cells
Won Jun Sohn, Jung Won Lee, Dong-Guk Park
J Korean Soc Coloproctol. 2010;26(4):246-253. Published online 2010 Aug 31 DOI: https://doi.org/10.3393/jksc.2010.26.4.246
|
|
Citations to this article as recorded by
 Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial
M Verstraete, A Debucquoy, J Dekervel, J van Pelt, C Verslype, E Devos, G Chiritescu, K Dumon, A D'Hoore, O Gevaert, X Sagaert, E Van Cutsem, K Haustermans
British Journal of Cancer.2015; 112(8): 1314. CrossRef Antichemosensitizing effect of resveratrol in cotreatment with oxaliplatin in HCT116 colon cancer cell
Dong-Guk Park
Annals of Surgical Treatment and Research.2014; 86(2): 68. CrossRef
|